Innoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
Innoveix Pharmaceuticals is recalling 413 vials of Lyophilized Human Chorionic Gonadotropin 5,000 USP Units due to a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in an injectable drug, which poses a significant risk of infection and potential hospitalization.
Plain-English summary
Innoveix Pharmaceuticals Inc is recalling 413 vials of Lyophilized Human Chorionic Gonadotropin 5,000 USP Units for injection. The recall is being conducted because of a lack of sterility assurance in the product.
The affected product is compounded by Innoveix in Addison, TX, and was distributed nationwide within the United States. The recall covers specific lots identified as INX 910 with an expiration date of 2/7/20 and INX 915 with an expiration date of 3/12/20.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Lyophilized Human Chorionic Gonadotropin 5,000 USP Units For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
- Manufacturer
- Innoveix Pharmaceuticals Inc
- Category
- Drug — Injectable
- Affected units
- 413
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: INX 910 Exp. 2/7/20
- INX 915 Exp. 3/12/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Innoveix Pharmaceuticals Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Innoveix Pharmaceuticals Inc
See all →- SevereCompounded Lyophilized AOD-9604 Injection Recalled for Sterility Risk
FDA (Drugs) · 2021-07-28
- SevereCompounded Semorelin/Ipamorelin Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-07-28
- SevereInnoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
Same hazard · infection
See all →- SevereStryker Bard EP XT Decapolar Steerable Diagnostic EP Catheter Recalled for Sterile Barrier Breach
FDA (Devices) · 2026-10-14
- SevereSafeguard US Operating LLC Recalls Compression Bandages Due to Degradation
FDA (Devices) · 2026-10-14
- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
Similar recalls
- HighKRS Global Biotechnology Recalls Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SeverePharm D Solutions Recalls Human Chorionic Gonadotropin Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereCompounded Lyophilized AOD-9604 Injection Recalled for Sterility Risk
FDA (Drugs) · 2021-07-28
- SevereCompounded Semorelin/Ipamorelin Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-07-28
- SeverePharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SeverePharm D Solutions Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-12-26